Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Lazzeri

Showing results (191-200 of 327) with videos related to

Pageof 33
Sort By:
European Urology Oncology|October 18, 2020
Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal TherapyVittorio Fasulo, Janet E Cowan, Martina Maggi, et al.
The Journal of Urology|February 19, 2014
Long-term followup and deterioration rate of anterior substitution urethroplastyGuido Barbagli, Sanjay B Kulkarni, Nicola Fossati, et al.
The Journal of Urology|August 29, 2020
The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease StageBianca Oresta, Daniele Braga, Massimo Lazzeri, et al.
Urology|March 26, 2013
Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapyAndrea Losa, Giulio Maria Gadda, Massimo Lazzeri, et al.
Cancers|October 27, 2022
The Role of [<sup>68</sup>Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic ReviewMatteo Caracciolo, Angelo Castello, Luca Urso, et al.
BJUI Compass|April 27, 2022
Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label studyRodolfo Hurle, Paolo Casale, Emanuela Morenghi, et al.
Urologic Oncology|October 15, 2021
Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment startRodolfo Hurle, Giorgio Guazzoni, Piergiuseppe Colombo, et al.
Biomed Research International|June 6, 2014
Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug targetFrancesco Mistretta, Nicolò Maria Buffi, Giovanni Lughezzani, et al.
European Urology Open Science|August 2, 2021
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center ExperienceMarco Paciotti, Paolo Casale, Piergiuseppe Colombo, et al.
European Urology|March 25, 2014
Robot-assisted, single-site, dismembered pyeloplasty for ureteropelvic junction obstruction with the new da Vinci platform: a stage 2a studyNicolò Maria Buffi, Giovanni Lughezzani, Nicola Fossati, et al.
Pageof 33

Showing results (191-200 of 327) with videos related to

Sort By:
Pageof 33
European Urology Oncology|October 18, 2020
Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal TherapyVittorio Fasulo, Janet E Cowan, Martina Maggi, et al.
The Journal of Urology|February 19, 2014
Long-term followup and deterioration rate of anterior substitution urethroplastyGuido Barbagli, Sanjay B Kulkarni, Nicola Fossati, et al.
The Journal of Urology|August 29, 2020
The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease StageBianca Oresta, Daniele Braga, Massimo Lazzeri, et al.
Urology|March 26, 2013
Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapyAndrea Losa, Giulio Maria Gadda, Massimo Lazzeri, et al.
Cancers|October 27, 2022
The Role of [<sup>68</sup>Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic ReviewMatteo Caracciolo, Angelo Castello, Luca Urso, et al.
BJUI Compass|April 27, 2022
Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label studyRodolfo Hurle, Paolo Casale, Emanuela Morenghi, et al.
Urologic Oncology|October 15, 2021
Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment startRodolfo Hurle, Giorgio Guazzoni, Piergiuseppe Colombo, et al.
Biomed Research International|June 6, 2014
Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug targetFrancesco Mistretta, Nicolò Maria Buffi, Giovanni Lughezzani, et al.
European Urology Open Science|August 2, 2021
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center ExperienceMarco Paciotti, Paolo Casale, Piergiuseppe Colombo, et al.
European Urology|March 25, 2014
Robot-assisted, single-site, dismembered pyeloplasty for ureteropelvic junction obstruction with the new da Vinci platform: a stage 2a studyNicolò Maria Buffi, Giovanni Lughezzani, Nicola Fossati, et al.
Pageof 33